Abstract
In 1937, the first antihistarninic compound was found by Bovet and Staub in one of a series of amines with a phenolic ether function. Although this compound, 2-isopropyl-5- methylphenoxyethyldiethylamine, protected guinea pigs not only from several lethal doses of histamine but also from the symptoms of anaphylactic shock, this drug was too toxic for clinical use. As a result of the following search for a histamine antagonist, pyrilamine maleate was found as one of the most specific and effective histamine antagonists in the early 1940’s. By the early 1950’s, many compounds having antihistaminic property had been described (Douglas, 1985). However, all these classical histamine antagonists (H1 antagonists) caused central side effects such as sedation, lassitude and drowsiness (Wyngaarden and Seevers, 1951). In addition, concurrent ingestion of alcohol and other eNS depressants produced an additive effect in impairing eNS actions, such as disturbing motor skills (Garrison, 1990).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Akagi, M., Mio, M., Tasaka, K. and Kiniwa, S.: Mechanism of histamine release inhibition induced by azelastine. Pharmacometrics, 26, 191–198 (1983)
Akagi, M., Mio, M., Miyoshi, K and Tasaka, K: Antiallergic effects of terfenadine on immediate type hypersensitivity reactions. Immunopharmacol. Immunotoxicol., 9, 257–279 (1987)
Akagi, M. and Tasaka, K: Analysis of bronchomotor tone in anesthetized guinea pigs by impedance plethysmography: a simple method for the evaluation of bronchodilator action. Meth. Find. Exp. Clin. Pharmacol., 10, 143–150 (1988)
Arunlakshana, O.: Histamine release by antihistamines. J. Physiol., 119, 47–48P (1953)
Awouters, F.H.L., Niemegeers, C. J. E. and Janssen, P.A.J.: Pharmacology of the specific histamine H1-antagonist astemizole. Arzneim.-Forsch., 33, 381–388 (1983)
Beaven, M.A., Rogers, J., Moore, J.P., Hesketh, T.R., Smith, G.A. and Metcalfe, J.C.: The mechanism of the calcium signal and correlation with histamine release in 2H3 cells. J. Biol. Chem., 259, 7129–7136 (1984)
Bende, M. and Pipkorn, U.: Topical levocabastine, a selective H1 antagonist, in seasonal allergic rhinoconjunctivitis. Allergy, 42, 512–515 (1987)
Bergmann, F., Costin, A. and Gutman, J.: A low threshold convulsive area in the rabbit’s mesencephalon. EEG Clin. Neurophysiol., 15, 683–690 (1963)
Bovet, D. and Staub, A.-M.: Action protectrice des éthers phénoliques au cours de l’intoxication histaminique. C.R. Soc. Biol., 124, 547–549 (1937)
Chand, N., Harrison, J.E., Rooney, S.M., Sofia, R.D. and Diamantis, W.: Inhibition of passive cutaneous anaphylaxis (PCA) by azelastine: Dissociation of its antiallergic activities from antihistaminic and antiserotonin properties. Int. J. Immunopharmacol., 7, 833–838 (1985)
Church, M. K and Gradidge, C.F.: Inhibition of histamine release from human lung in vitro by antihistamines and related drugs. Br. J. Pharmacol., 69, 663–667 (1980)
Cooley, J.W. and Tukey, J.S.: An algorithm for machine calculation of complex Fourier series. Math. Comput., 19, 267–301 (1965)
Criscuoli, M., Subissi, A., Daffonchio, L. and Omini, C.: LG 30435, a new bronchodilator / antiallergic agent, inhibits PAF -acether induced platelet aggregation and bronchoconstriction. Agents Actions, 19, 246–250 (1986)
de Groot, J.: The rat forebrain in stereotaxic coordinates, Verh. K Ned. Acad. Wet. Naturkund., 52, 1–40 (1959)
Douglas, W.W.: Histamine and 5-hydroxytryptamine (serotonin) and their antagonist. In: Gilman, A.G., Goodman, L.S., Rall, T.W., Murad, F. (ed) Goodman and Gilman’s The Pharmacological Basis of Therapeutics, 7th ed. Macmillan Publishing Co., New York., 524–627, 1985
Fukuda, T., Morimoto, Y., Iemura, R., Kawashima, T., Tsukamoto, G. and Ito, K.: Effect of 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)-benzimidazole difumarate (KB-2413), a new antiallergic, on chemical mediators. Arzneim.-Forsch., 34, 801–805 (1984)
Fügner, A., Bechtel, W.D., Kuhn, F.J. and Mierau, J.: In vitro and in vivo studies of the non-sedating antihistamine epinastine. Arzneim. - Forsch., 38, 1446–1453 (1988)
Garrison, J.C.: Histamine, bradykinin, 5-hydroxytryptamine, and their antagonists, In: Gilman, A.G., Rall, T.W., Nies, A.S. and Taylor, P. (ed) Goodman and Gilman’s The Pharmacological Basis of Therapeutics, 8th ed. Pergamon Press, New York, pp.575–599,. 1990
Goldstein, L., Murphree, H.B., Pfeiffer, C.C: Comparative study of EEG effects of antihis tamines in nonnal volunteers. J. Clin. Phannacol., 8, 42–53 (1968)
Guesdon, J.L., Chevrier, D., Mazié, J.C., David, B. and Avrameas, S.: Monoclonal antihistamine antibody, preparation, characterization and application to enzyme immunoassay of histamine. J. Immunol. Methods, 87, 69–78 (1986)
Hall, C.S.: Emotional behavior in the rat. III. The relationship between emotionality and ambulatory activity. J. Compo Psychol., 22, 345–352 (1936)
Hayashi, H., Ichikawa, A., Saito, T. and Tomita, K: Inhibitory role of cyclic adenosine 3′, 5′ -monophosphate in histamine release from rat peritoneal mast cells in vitro. Biochem. Phannacol., 25, 1907–1913 (1976)
Kamei, C., Kiniwa S., Ikegami, N. and Tasaka, K: Effect of 4-(p-chlorobenzyl)-[Nmethylperhydroazepinyl-(4)] -1-(2H)-phthalazinone hydrochloride (azelastine) on EEGs and behavior in rats. Jpn. J. Clin. Pharmacol. Ther., 12, 297–310 (1981)
Kamei, C., Akahori, H. and Tasaka, K: Influence of histamine and related compounds on the hypnotic effect of thiopental in mice. J. Pharmacobio-Dyn., 9, 112–116 (1986)
Kamei, C., Chung, Y.H. and Tasaka, K: Influence of certain H1-blockers on the stepthrough active avoidance response in rats. Psychopharmacology, 102, 312–318 (1990)
Kamei, C., Mio, M., Izushi, K, Kitazumi, K, Tsujimoto, S., Fujisawa, K, Adachi, Y. and Tasaka, K: Antiallergic effects of major metabolites of astemizole in rats and guinea pigs. Arzneim.-Forsch., 41, 932–936 (1991a)
Kamei, C., Mio, M., Izushi, K, Yoshii, N., Fujisawa, K, and Tasaka, K: Inhibitory effect of MY-1250 on histamine release from rat peritoneal mast cells and guinea pig lung fragments: The elucidation of the mechanism. Immunophannacol. Immunotoxicol., 13, 341–356 (1991b)
Kamei, C., Izushi, K and Tasaka, K: Inhibitory effect of levocabastine on experimental allergic conjunctivitis in guinea pigs. J. Phannacobio-Dyn., 14, 467–473 (1991c)
Kamei, C., Akagi, M., Mio, M., Kitazumi, K, Izushi, K, Masaki, S. and Tasaka, K: Antiallergic effect of epinastine (W AL 801 CL) on immediate hypersensitivity reactions: (I) Elucidation of the mechanism for histamine release inhibition. Immunophannacol. Immunotoxicol., 14, 191–205 (1992a)
Kamei, C., Mio, M., Kitazumi, K, Tsujimoto, S., Yoshida, T., Adachi, Y. and Tasaka, K: Antiallergic effect of epinastine (WAI 801 CL) on immediate hypersensitivity reactions: (II) Antagonistic effect of epinastine on chemical mediators, mainly antihistaminic and anti-PAF effects. Immunophannacol. Immunotoxicol., 14, 207–218 (1992b)
Kamei, C., Okumura, Y. and Tasaka, K: Influence of histamine depletion on learning and memory recollection in rats. Psychophannacology, 111, 376–382 (1993)
Kaneko, T., Kitahara, A., Ozaki, S., Takizawa, K and Yamatsu, K: Effects of azelastine hydrochloride, a novel anti-allergic drug, on the central nervous system. Arzneim. - Forsch., 31, 1206–1212 (1981)
Kebabian, J.W., Petzold, G.L. and Greegard, P.: Dopamine-sensitive adenylate cyclase in caudate nucleus of rat brain, and its similarity to the “Dopamine Receptor”. Proc. Natl. Acad. Sci., 69, 2145–2149 (1972)
Koster, R., Anderson, M. and de Beer, E.J.: Acetic acid for analgesic screening. Fed. Proc., 18, 412 (1959)
Kojima, M., Tsutsumi, N., Abe, M., Komatsu, H., Ujiie, A., Naito, J. and Nakazawa, M.: Experimental allergic rhinitis in rats and the influence of tranilast and antihistaminics on it. Jpn. J. Allergol., 35, 180–187 (1986)
Kreindler, A., Zuckermann, E., Steriade, M. and Chimion, D.: Electroclinical features of convulsions induced by stimulation of brain stem. J. Neurophysiol., 21, 430–436 (1958)
Lau, H.Y.A. and Pearce, F.L.: Dual effect of antihistamines on rat peritoneal mast cells: induction and inhibition of histamine release. Agents Actions, 16, 176–178 (1985)
Leavitt, M.D. and Code, C.F.: Anesthetic action of beta-dimethylaminoethyl benzhydryl ether hydrochloride (benadryl) in the skin of human beings. Proc. Soc. expo Biol. (N.Y.), 65, 33–38 (1947)
Levine, B.B. and Vaz, N.M.: Effect of combinations of inbred strain, antigen, and antigen dose on immune responsiveness and reagin production in the mouse. Int. Arch. Allergy, 39, 156–171 (1970)
Lewis, A.J., Dervinis, A. and Chang, J.: The effects of antiallergic and bronchodilator drugs on platelet-activating factor (PAF-acether) induced bronchospasm and platelet aggregation. Agents Actions, 15, 636–642 (1984)
Loeffler, L.J., Lovenberg, W. and Sjoerdsma, A.: Effects of dibutyryl-3′, 5′-cyclic adenosine monophosphate, phosphodiesterase inhibitors and prostaglandin E1 on compound 48/80-induced histamine release from rat peritoneal mast cells in vitro. Biochem. Pharmacol., 20, 2287–2297 (1971)
McManus, L.M., Hanahan, D.J., Demopoulos, C.A. and Pinckard, RN.: Pathobiology of the intravenous infusion of acetyl glyceryl ether phosphorylcholine (AGEPC), a synthetic platelet-activating factor (PAF), in the rabbit. J. Immunol., 124, 2919–2924 (1980)
Martin, U. and Römer, D.: The pharmacological properties of a new, orally active antianaphylactic compound: Ketotifen, a benzocycloheptathiophene. Arzneim. - Forsch., 28, 770–782 (1978)
Mota, I.: The mechanism of anaphylaxis. I. Production and biological properties of ‘mast cell sensitizing’ antibody. Immunology, 7, 681–699 (1964)
Naranjo, P. and Naranjo, E.B. De: Local anesthetic activity of some antihistamines and its relationship with the antihistaminic and anticholinergic activities. Arch. int. Pharmacodyn., 113, 313–335 (1958)
Nemeth, A. and Röhlich, P.: Rapid separation of rat peritoneal mast cells with Percoll. Eur. J. Cell Biol., 20, 272–275 (1980)
Ohmori, K, Ishii, H., Kubota, T., Shuto K and Nakamizo, N.: Inhibitory effects of oxatomide on several activities of SRS-A and synthetic leukotrienes in guinea pigs and rats. Arch. int. Pharmacodyn., 275, 139–150 (1985)
Ohmori, K, Ishii, H., Shuto, K and Nakamizo, N.: Pharmacological studies on oxatomide: (4) Effect on the histamine release from rat isolated peritoneal exudate cells (PEC) and lung slices. Folia pharmacol. japon., 80, 441–449 (1982)
Patel, KR: The effect of calcium antagonist, nifedipine in exercise-induced asthma. Clin. Allergy, 11, 429–432 (1981)
Pellerat, J. and Murat, M.: Action des antihistaminiques de synthese sur l’histaminemie. C.R Soc. Biol. (Paris), 140, 297 (1946)
Pöch, G.: Assay of phosphodiesterase with radioactively labeled cyclic 3′, 5′-AMP as substrate. Naunyn-Schmiedebergs Arch. Pharmak., 268, 272–299 (1971)
Ritchie, D.M., Sierchio, J.N., Bishop, C.M., Hedli, C.C., Levinson, S.L. and Capetola, R J.: Evaluation of calcium entry blockers in several models of immediate hypersensitivity. J. Phannacol. Exp. Ther., 229, 690–695 (1984)
Ross, E.M., Maguire, M.E., Sturgill, T.W., Biltonen, R.L. and Gilman, A.G.: Relationship between the β-adrenergic receptor and adenylate cyclase. J. Biol. Chern., 252, 5761–5775 (1977)
Siraganian, R.P.: An automated continuous-flow system for the extraction and fluorometric analysis of histamine. Anal. Biochem., 57, 383–394 (1974)
Spataro, AC. and Bosmann, H.B.: Mechanism of action of disodium cromoglycate-mast cell calcium ion influx after a histamine-releasing stimulus. Biochem. Phannacol., 25, 505–510 (1976)
Shore, P.A., Burkhalter, A and Cohn, V.H.: A method for the fluorometric assay of histamine in tissues. J. Pharmacol. Exp. Ther., 127, 182–187 (1959)
Swinyard, E.A, Jolley, J.M. and Goodman, L.S.: Anticonvulsant properties of benadryl and pyribenzamine. Proc. Soc. Exp. Biol. Med., 75, 239–242 (1950)
Tada, T. and Okumura, K.: Regulation of homocytotropic antibody formation in the rat. I. Feed-back regulation by passively administered antibody. J. Immunol., 106, 1002–1011 (1971)
Tasaka, K.: Histamine release and its inhibition by antihistamines. Folia pharmacol, japon., 53, 1029–1035 (1957)
Tasaka, K. and Akagi, M.: Anti-allergic properties of a new histamine antagonist, 4-(p-Chlorobenzyl)-2- [N-methyl-perhydroazepinyl-(4)]-1-(2H)-phthalazinone hydrochloride (Azelastine). Arzneim.-Forsch., 29, 488–493 (1979)
Tasaka, K., Kamei C., Akahori H. and Kitazumi, K.: The effects of histamine and some related compounds on conditioned avoidance response in rats. Life Sci., 37, 2005–2014 (1985)
Tasaka, K., Mio, M. and Okamoto, M.: Intracellular calcium release induced by histamine releasers and its inhibition by some antiallergic drugs. Ann. Allergy, 56, 464–469 (1986a)
Tasaka, K., Mio, M., Okamoto, M.: Changes in intracellular Ca2+ distribution of rat peritoneal mast cells before and after histamine release. Agents Actions, 18, 61–64 (1986b)
Tasaka, K., Kamei C., Katayama, S., Kitazumi, K., Akahori, H. and Hokonohara, T.: Comparative study of various H1-blockers on neuropharmacological and behavioral effectS including 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl) benzimidazole difumarate (KB-2413), a new antiallergic agent. Arch. int. Pharmacodyn., 280, 275–291 (1986c)
Tasaka, K., Akagi, M., Mio, M., Miyoshi, K. and Nakaya, N.: Inhibitory effects of oxatomide on intracellular Ca mobilization, Ca uptake and histamine release, using rat peritoneal mast cells. Int. Archs Allergy appl. Immun., 83, 348–353 (1987)
Tasaka, K., Akagi, M., Mio, M., Okamoto, M., Miyoshi, K. and Izushi, K.: Antiallergic effects of terfenadine on immediate type hypersensitivity reactions and the mechanisms of those actions. Jpn. Pharmacol. Ther., 16, 2465–2480 (1988)
Tasaka, K., Chung, Y.H., Sawada, K. and Mio, M.: Excitatory effect of histamine on the arousal system and its inhibition by H1 blockers. Brain Res. Bull., 22, 271–275 (1989a)
Tasaka, K., Kamei C., Tsujimoto, S., Chung, Y.H. and Nakano, S.: Effects of mequitazine and some other HI-blockers on the central nervous system. Pharmacometrics, 37, 509–516 (1989b)
Tasaka, K., Kamei C., Nakano, S., Tsujimoto, S. and Chung, Y.H.: Effect of epinastine, a new antiallergic agent, on the central nervous system. Pharmacometrics, 38, 53–62 (1989c)
Tasaka, K., Akagi, M., Izushi, K. and Mio, M.: Antiallergic effects of astemizole on immediate type hypersensitivity reactions. Meth. Find. Exp. Clin. Pharmacol., 12, 531–539 (1990a)
Tasaka, K., Kamei, C., Chung, Y.H., Tsujimoto, S. and Mukai, T.: Influence of astemizole, a non-sedative H1-blocker on the central nervous system. Pharmacometrics., 39, 197–206 (1990b)
Tasaka, K., Kamei, C., Tsujimoto, S., Yoshida, T. and Aoki, I.: Central effect of the potent long-acting H1-antihistamine levocabastine. Arzneim. - Forsch., 40, 1295–1299 (1990c)
Tasaka, K., Akagi, M., Izushi, K. and Aoki, I.: Antiallergic effect of epinastine: the elucidation of the mechanism. Pharmacometrics, 39, 365–373 (1990d)
Tasaka, K., Akagi, M., Mio, M., Izushi, K. and Aoki, I.: Anti-platelet activating factor, anti-leukotriene D4 and some other antiallergic activities of mequitazine. Arzneim. - Forsch., 40, 1092–1097 (1990e)
Tasaka, K., Kamei, C., Akagi, M., Mio, M., Shirasaka, T. and Chokki, M.: Antiallergic profile of the novel H1-antihistaminic compound levocabastine. Arzneim.-Forsch., 43, 1331–1337 (1993)
Tasaka, K., Kamei C. and Nakamura, S.: Inhibitory effect of epinastine on bronchoconstriction induced by histamine, platelet activating factor and serotonin in guinea pigs and rats. Arzneim. - Forsch., 44, 327–329 (1994a)
Tasaka, K., Kamei, C. and Nakamura, S.: Effects of antiallergic agents including levocabastine on experimental rhinitis in rats. Arzneim.-Forsch., 44, 337–341 (1994b)
Vargaftig, B.B., Lefort, J., Chignard, M. and Benveniste, J.: Platelet-activating factor induces a platelet-dependent bronchoconstriction unrelated to the formation of prostaglandin derivatives. European J. Pharmacol., 65, 185–192 (1980)
Venuti M.C.: Platelet-activating factor: multifaceted biochemical and physiological mediator. Ann. Rep. Med. Chern., 20, 193–202 (1985)
Wauwe, J. Van., Awouters, F., Niemegeers, C.J.E., Janssens, F., Neuten, J.M. Van and Janssen, P.A.J.: In vivo pharmacology of astemizole, a new type of HI-antihistaminic compound. Arch. int Pharmacodyn., 251, 39–51 (1981)
Weidmann, H. and Petersen, P.V.: A new group of potent sedatives. J. Pharmacol. Exp. Ther., 108, 201–216 (1953)
White, J.R., Ishizaka, T., Ishizaka, K. and Sha’afi R.I.: Direct demonstration of increased intracellular concentration of free calcium as measured by quin-2 in stimulated rat peritoneal mast cell. Proc. Natl. Acad. Sci. U.S.A., 81, 3978–3982 (1984)
Winter, C.A. The potentiating effect of antihistaminic drugs upon the sedative action of barbiturates. J. Pharmacol. Exp. Ther., 94, 7–11 (1948)
Winter, C.A. and Flataker, L.: The effect of antihistaminic drugs upon the performance of trained rats. J. Pharmacol. Exp. Ther., 101, 156–162 (1951)
Wyngaarden, J.B. and Seevers, M.H.: The toxic effects of antihistaminic drugs. J. Amer. Med. Ass., 145, 277–282 (1951)
Yamasaki, H. and Tasaka, K.: Dual action of antihistamines on histamine release. Acta Med. Okayama, 11, 290–299 (1957)
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer-Verlag Tokyo
About this chapter
Cite this chapter
Tasaka, K. (1994). Pharmacology of newly developed H1 antagonists: antiallergic profile of H1 antagonists. In: New Advances in Histamine Research. Springer, Tokyo. https://doi.org/10.1007/978-4-431-68263-9_9
Download citation
DOI: https://doi.org/10.1007/978-4-431-68263-9_9
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-68265-3
Online ISBN: 978-4-431-68263-9
eBook Packages: Springer Book Archive